These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Studies of the metabolism of methotrexate. II. Isolation and identification of several unconjugated aminopteridines as metabolites in the rat. Valerino DM Res Commun Chem Pathol Pharmacol; 1972 Nov; 4(3):529-42. PubMed ID: 4638591 [No Abstract] [Full Text] [Related]
7. Pharmacologic studies of methotrexate in cancer patients with uropathy. Ojima Y; Anderson LL; Collins GJ; Oberfield RA; Sullivan RD Arch Surg; 1970 Feb; 100(2):173-7. PubMed ID: 5411410 [No Abstract] [Full Text] [Related]
8. Clinical pharmacology of very low dose methotrexate for use in rheumatoid arthritis. Furst DE J Rheumatol Suppl; 1985 Dec; 12 Suppl 12():11-4. PubMed ID: 3913770 [TBL] [Abstract][Full Text] [Related]
9. Methotrexate. I. Pharmacology and pharmacokinetics. Lippens RJ Am J Pediatr Hematol Oncol; 1984; 6(4):379-95. PubMed ID: 6398629 [TBL] [Abstract][Full Text] [Related]
10. Collateral sensitivity to methotrexate in cells resistant to adriamycin. Herman TS; Cress AE; Gerner EW Cancer Res; 1979 Jun; 39(6 Pt 1):1937-42. PubMed ID: 445393 [No Abstract] [Full Text] [Related]
11. Topical treatment of psoriatic skin with methotrexate cream: a clinical, pharmacokinetic, and histological study. Bjerring P; Beck HI; Zachariae H; Søgaard H Acta Derm Venereol; 1986; 66(6):515-9. PubMed ID: 2433872 [TBL] [Abstract][Full Text] [Related]
12. Tissue pharmacokinetics, inhibition of DNA synthesis and tumor cell kill after high-dose methotrexate in murine tumor models. Sirotnak FM; Donsbach RC; Dorick DM; Moccio DM Cancer Res; 1976 Dec; 36(12):4672-8. PubMed ID: 1000510 [TBL] [Abstract][Full Text] [Related]
13. [Experimental research on the effect of methotrexate on the proliferative capability of rat epidermis]. Piletić O; Unković N; Popović S Dermatol Monatsschr; 1974 Jan; 160(1):12-7. PubMed ID: 4839812 [No Abstract] [Full Text] [Related]
14. High-dose methotrexate therapy--an area of uncertainty. Paxton JW Aust N Z J Med; 1979 Dec; 9(6):722-32. PubMed ID: 394737 [No Abstract] [Full Text] [Related]
15. [Clinical pharmacokinetics of high dose methotrexate]. Zhang XG; Wu DZ Yao Xue Xue Bao; 1983 Nov; 18(11):801-7. PubMed ID: 6679971 [No Abstract] [Full Text] [Related]
17. Recent concepts on the mechanism of action of methotrexate. White JC Cancer Treat Rep; 1981; 65 Suppl 1():3-12. PubMed ID: 7326663 [No Abstract] [Full Text] [Related]
18. Reversibility of high-affinity binding of methotrexate in L1210 murine leukemia cells. Cohen M; Bender RA; Donehower R; Myers CE; Chabner BA Cancer Res; 1978 Sep; 38(9):2866-70. PubMed ID: 679194 [No Abstract] [Full Text] [Related]
19. Methotrexate loaded lipid nanoparticles for topical management of skin-related diseases: Design, characterization and skin permeation potential. Ferreira M; Silva E; Barreiros L; Segundo MA; Costa Lima SA; Reis S Int J Pharm; 2016 Oct; 512(1):14-21. PubMed ID: 27530292 [TBL] [Abstract][Full Text] [Related]
20. Clinical pharmacokinetics of methotrexate in psoriasis therapy. Hendel J Dan Med Bull; 1985 Dec; 32(6):329-37. PubMed ID: 3908004 [No Abstract] [Full Text] [Related] [Next] [New Search]